Curcumin, a golden spice with a low bioavailability

Adams, 2005, EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism, Anticancer Drugs, 16, 263, 10.1097/00001813-200503000-00005 Ahsan, 1998, Strand scission in DNA induced by curcumin in the presence of Cu(II), Cancer Lett, 124, 23, 10.1016/S0304-3835(97)00442-4 Ahsan, 1999, Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin, Chem Biol Interact, 121, 161, 10.1016/S0009-2797(99)00096-4 Aggarwal, 2005, Curcumin derived from turmeric (Curcuma longa): a spice for all seasons, 349 Aggarwal, 2003, Anticancer potential of curcumin: preclinical and clinical studies, Anticancer Res, 23, 363 Ammon, 1991, Pharmacology of Curcuma longa, Planta Med, 57, 1, 10.1055/s-2006-960004 Anand, 2010, Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo, Biochem Pharmacol, 79, 330, 10.1016/j.bcp.2009.09.003 Antony, 2008, A pilot cross-over study to evaluate human oral bioavailability of BCM-95® CG (Biocurcumax™), a novel bioenhanced preparation of curcumin, Indian J Pharm Sci, 70, 445, 10.4103/0250-474X.44591 Baglole, 2005, Fluorescence enhancement of curcumin upon inclusion into parent and modified cyclodextrins, J Photochem Photobiol, 173, 230, 10.1016/j.jphotochem.2005.04.002 Balasubramanian, 2004, Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancerbinding protein function, J Biol Chem, 279, 24007, 10.1074/jbc.M314331200 Bamba, 2011, Compounds isolated from Curcuma aromatica Salisb. inhibit human P450 enzymes, J Nat Med, 65, 583, 10.1007/s11418-011-0507-0 Bernabé-Pineda, 2004, Determination of acidity constants of curcumin in aqueous solution and apparent rate constant of its decomposition, Spectrochim Acta A Mol Biomol Spectrosc, 60, 1091, 10.1016/S1386-1425(03)00342-1 Bisht, 2007, Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy, J Nanobiotechnol, 5, 3, 10.1186/1477-3155-5-3 Bhowmik, 2009, Turmeric: a herbal and traditional medicine, Arch Appl Sci Res, 1, 86 Carroll, 2011, Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia, Cancer Prev Res (Phila), 4, 354, 10.1158/1940-6207.CAPR-10-0098 Chen, 2012, N trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin, J Liposome Res, 22, 100, 10.3109/08982104.2011.621127 Chen, 2013, Inhibition of enveloped viruses infectivity by curcumin, PLOS ONE, 8, e62482, 10.1371/journal.pone.0062482 Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res, 21, 2895 Cruz-Correa, 2006, Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis, Clin Gastroenterol Hepatol, 4, 1035, 10.1016/j.cgh.2006.03.020 Cui, 2008, Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment, Biol Pharm Bull, 31, 118, 10.1248/bpb.31.118 Cuomo, 2011, Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation, J Nat Prod, 74, 664, 10.1021/np1007262 Dayton, 2010, Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties, Cancer Biol Ther, 10, 1027, 10.4161/cbt.10.10.13250 Dhillon, 2008, Phase II trial of curcumin in patients with advanced pancreatic cancer, Clin Cancer Res, 14, 4491, 10.1158/1078-0432.CCR-08-0024 Fang, 2005, Thioredoxin reductase is irreversibly modified by curcumin: anovel molecular mechanism for its anticancer activity, J Biol Chem, 280, 25284, 10.1074/jbc.M414645200 Fang, 2003, Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin, J Pharm Pharmacol, 55, 593, 10.1211/002235703765344496 Feng, 2012, Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles, Int J Nanomed, 7, 4089, 10.2147/IJN.S33607 Gagliardi, 2012, Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to beta-amyloid clearance, Chem Res Toxicol, 25, 101, 10.1021/tx200246t Galati, 2002, Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics, Toxicology, 177, 91, 10.1016/S0300-483X(02)00198-1 Gao, 2012, In vivo evaluation of curcumin loaded nanosuspensions by oral administration, J Biomed Nanotechnol, 8, 659, 10.1166/jbn.2012.1425 Gao, 2010, Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer, Drug Dev Ind Pharm, 36, 1225, 10.3109/03639041003695139 Gupta, 2010, Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals, Cancer Metastasis Rev, 29, 405, 10.1007/s10555-010-9235-2 Gupta, 2011, Multitargeting by curcumin as revealed by molecular interaction studies, Nat Prod Rep, 28, 1937, 10.1039/c1np00051a Han, 2008, In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression, Toxicol Appl Pharmacol, 230, 283, 10.1016/j.taap.2008.02.026 Hoehle, 2006, Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver, J Agric Food Chem, 54, 756, 10.1021/jf058146a Holder, 1978, The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat, Xenibiotica, 8, 761, 10.3109/00498257809069589 Huang, 1991, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis, Cancer Res, 51, 813 Jagatha, 2008, Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies, Free Radic Biol Med, 44, 907, 10.1016/j.freeradbiomed.2007.11.011 Jaiswal, 2010, Polycaprolactone diacrylate crosslinked biodegradable semi-interpenetrating networks of polyacrylamide and gelatin for controlled drug delivery, Biomed Mater, 5, 065014, 10.1088/1748-6041/5/6/065014 John, 2013, Development and pharma-cokinetic evaluation of a curcumin co-solvent formulation, Anticancer Res, 33, 4285 Jung, 2011, Enhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique, Biol Pharm Bull, 34, 1179, 10.1248/bpb.34.1179 Jurenka, 2009, Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa. A preclinical and clinical research, Altern Med Rev, 14, 2 Khalil, 2013, Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats, Colloids Surf B Biointerfaces, 101, 353, 10.1016/j.colsurfb.2012.06.024 Kakkar, 2011, Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin, Mol Nutr Food Res, 55, 495, 10.1002/mnfr.201000310 Kanai, 2014, Therapeutic applications of curcumin for patients with pancreatic cancer, World J Gastroenterol, 20, 9384 Kanai, 2012, Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers, Cancer Chemother Pharmacol, 69, 65, 10.1007/s00280-011-1673-1 Kelley, 2008, Alternative medicine and Alzheimer disease, Neurologist, 14, 299, 10.1097/NRL.0b013e318172cf4d Khajuria, 1998, Permeability characteristics of piperine on oral absorption—an active alkaloid from peppers and a bioavailability enhancer, Indian J Exp Biol, 36, 46 Khopde, 2000, Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis, Biosci Biotechnol Biochem, 64, 503, 10.1271/bbb.64.503 Kidd, 2009, Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts, Altern Med Rev, 14, 226 Kunwar, 2009, Curcumin mediates time and concentration dependent regulation of redox homeostasis leading to cytotoxicity in macrophage cells, Eur J Pharmacol, 611, 8, 10.1016/j.ejphar.2009.03.060 Kurd, 2008, Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial, J Am Acad Dermatol, 58, 625, 10.1016/j.jaad.2007.12.035 Kuo, 1996, Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells, Biochim Biophys Acta, 1317, 95, 10.1016/S0925-4439(96)00032-4 Li, 2012, Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin, Int J Nanomed, 7, 5995, 10.2147/IJN.S38043 Lin, 2008, Curcumin: a potential cancer chemopreventive agent through suppressing NF-κB signaling, J Cancer, 4, 11 Liu, 2006, Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin, J Pharm Biomed Anal, 40, 720, 10.1016/j.jpba.2005.09.032 Mach, 2010, Evaluation of liposomal curcumin cytochrome p450 metabolism, Anticancer Res, 30, 811 Madsen B, Hidalgo GV, Hernandez VL. Purification process for improving total yield of curcuminoid colouring agent. United States Patent 6,576,273; 2003. Majumdar, 2009, Curcumin synergizes with resveratrol to inhibit colon cancer, Nutr Cancer, 61, 544, 10.1080/01635580902752262 Marathe, 2011, Multifaceted roles of curcumin: two sides of a coin!, Expert Opin Biol Ther, 11, 1485, 10.1517/14712598.2011.623124 Marcu, 2006, Curcumin is an inhibitor of p300 histone acetylatransferas, Med Chem, 2, 169, 10.2174/157340606776056133 Marczylo, 2007, Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine, Cancer Chemother Pharmacol, 60, 171, 10.1007/s00280-006-0355-x Mazzarino, 2012, Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications, J Colloid Interface Sci, 370, 58, 10.1016/j.jcis.2011.12.063 Negi, 1999, Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture, J Agric Food Chem, 47, 4297, 10.1021/jf990308d Nishiyama, 2005, Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice, J Agric Food Chem, 53, 959, 10.1021/jf0483873 Okura, 2010, Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells, Biol Pharm Bull, 33, 255, 10.1248/bpb.33.255 Pan, 1999, Biotransformation of curcumin through reduction and glucuronidation in mice, Drug Metab Dispos, 27, 486 Panahi, 2011, Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomized, double-blind, placebocontrolled trial, Br J Nutr, 18, 1 Perkins, 2002, Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS, Cancer Epidemiol Biomarkers Prev, 11, 535 Perkins, 2002, Chemopreventive efficacy and pharmacokinetics of curcumin in the min/mouse, a model of familial adenomatous polyposis, Cancer Epidemiol Biomarkers, 11, 535 Priyadarsini, 2003, Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin, Free Radic Biol Med, 35, 475, 10.1016/S0891-5849(03)00325-3 Price, 2008, Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes, Xenobiotica, 38, 574, 10.1080/00498250802008615 Rachmawati, 2013, Molecular inclusion complex of curcumin-beta-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel, AAPS PharmSciTech, 14, 1303, 10.1208/s12249-013-0023-5 Ran, 1988, New methods for isolation of curcumin, Shipin Kexue (Beijing), 101, 12 Ravindranath, 1980, Absorption and tissue distribution of curcumin in rats, Toxicology, 16, 259, 10.1016/0300-483X(80)90122-5 Ravindran, 2007, 235 Reuter, 2011, Epigenetic changes induced by curcumin and other natural compounds, Genes Nutr, 6, 93, 10.1007/s12263-011-0222-1 Ringman, 2012, Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind,placebo-controlled study, Alzheimers Res Ther, 4, 43, 10.1186/alzrt146 Sandur, 2007, Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane), Free Radic Biol Med, 43, 568, 10.1016/j.freeradbiomed.2007.05.009 Sarkar, 2008, NF-kappa signaling pathway and its therapeutic implications in human diseases, Int Rev Immunol, 27, 293, 10.1080/08830180802276179 Sasaki, 2011, Innovative preparation of curcumin for improved oral bioavailability, Biol Pharm Bull, 34, 660, 10.1248/bpb.34.660 Sethi, 2009, Targeting TNF for treatment of cancer and autoimmunity, Adv Exp Med Biol, 647, 37, 10.1007/978-0-387-89520-8_3 Sidhu, 1998, Enhancement of wound healing by curcumin in animals, Wound Repair Regen, 6, 167, 10.1046/j.1524-475X.1998.60211.x Shaikha, 2009, Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-times when compared to curcumin administered with piperine as absorption enhancer, Eur J Pharm Sci, 37, 223, 10.1016/j.ejps.2009.02.019 Sharma, 1976, Antioxidant activity of curcumin and related compounds, Biochem Pharmacol, 25, 1811, 10.1016/0006-2952(76)90421-4 Sharma, 2004, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin Cancer Res, 10, 68476854, 10.1158/1078-0432.CCR-04-0744 Sharma, 2006, Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats, Clin Exp Pharmacol Physiol, 33, 940, 10.1111/j.1440-1681.2006.04468.x Shehzad, 2010, Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials, Arch Pharm Chem Life Sci, 9, 489, 10.1002/ardp.200900319 Shishodia, 2005, Curcumin: getting back to the roots, Ann N Y Acad Sci, 1056, 206, 10.1196/annals.1352.010 Shishodia, 2007, Modulation of transcription factors by curcumin, Adv Exp Med Biol, 595, 127, 10.1007/978-0-387-46401-5_4 Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med, 64, 353, 10.1055/s-2006-957450 Gupta, 2011, Multitargeting by curcumin as revealed by molecular interaction studies, Nat Prod Rep, 28, 1937, 10.1039/c1np00051a Sugiyama, 1996, Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin, Biochem Pharmacol, 52, 519, 10.1016/0006-2952(96)00302-4 Takahashi, 2008, Characterization and bioavailability of liposomes containing a ukon extract, Biosci Biotechnol Biochem, 72, 1199, 10.1271/bbb.70659 Takahashi, 2009, Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin, J Agric Food Chem, 57, 9141, 10.1021/jf9013923 Tønnesen, 2002, Studies of curcumin and curcuminoids XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability, Int J Pharm, 244, 127, 10.1016/S0378-5173(02)00323-X Tønnesen, 2006, Solubility and stability of curcumin in solutions containing alginate and other viscosity modifying macromolecules. Studies of curcumin and curcuminoids. XXX, Pharmazie, 61, 696 Tsai, 2012, Effects of polymer molecular weight on relative oral bioavailability of curcumin, Int J Nanomed, 7, 2957, 10.2147/IJN.S32630 Vareed, 2008, Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects, Cancer Epidemiol Biomarkers Prev, 17, 1411, 10.1158/1055-9965.EPI-07-2693 Verma, 1997, Curcumin and genistein, plant natural products, show sinergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides, Biochem Biophys Res Commun, 233, 692, 10.1006/bbrc.1997.6527 Villegas, 2008, New mechanisms and therapeutic potential of curcumin for colorectal cancer, Mol Nutr Food Res, 52, 1040, 10.1002/mnfr.200700280 Volak, 2008, Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor, Drug Metab Dispos, 36, 1594, 10.1124/dmd.108.020552 Volak, 2013, Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers, Br J Clin Pharmacol, 75, 45062, 10.1111/j.1365-2125.2012.04364.x Wahlstrom, 1978, A study on the fate of curcumin in the rat, Acta Pharmacol Toxicol, 43, 86, 10.1111/j.1600-0773.1978.tb02240.x Wahlang, 2011, Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model, Eur J Pharm Biopharm, 77, 275, 10.1016/j.ejpb.2010.12.006 Wang, 1997, Stability of curcumin in buffer solutions and characterization of its degradation products, J Pharm Biomed Anal, 15, 18671876, 10.1016/S0731-7085(96)02024-9 Xie, 2011, PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms, J Agric Food Chem, 59, 9280, 10.1021/jf202135j Yadav, 2009, Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model, AAPS PharmSciTech, 10, 3, 10.1208/s12249-009-9264-8 Yallapu, 2010, Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells, J Colloid Interface Sci, 351, 19, 10.1016/j.jcis.2010.05.022 Zhang, 2014, Effects of curcumin on ion channels and transporters, Front Physiol, 5, 94 Zhang, 2012, Physical characterization and cellular uptake of propylene glycol liposomes in vitro, Drug Dev Ind Pharm, 38, 365, 10.3109/03639045.2011.604331 Zhongfa, 2012, Enhancement of curcumin oral absorption and pharma-cokinetics of curcuminoids and curcumin metabolites in mice, Cancer Chemother Pharmacol, 69, 679, 10.1007/s00280-011-1749-y Zhou, 2014, Curcumin analogues with high activity for inhibiting human prostate cancer cell growth andandrogen receptor activation, Mol Med Rep, 10, 1315, 10.3892/mmr.2014.2380